Search Results 201-210 of 17592 for what is vedolizumab

1. Crohn's disease - Doctors and departments - Mayo Clinic

   Current research to refine and enhance minimally invasive intestinal surgery could benefit people with Crohn's disease in the future. Doctors at Mayo Clinic ...

2. Crohn's disease - Doctors and departments - Mayo Clinic

   Mayo Clinic researchers are working to improve diagnosis and treatment of Crohn's disease. Radiologists at Mayo Clinic were instrumental in developing novel ...

3. Crohn's disease - Doctors and departments - Mayo Clinic

   Mayo Clinic researchers are working to improve diagnosis and treatment of Crohn's disease. Radiologists at Mayo Clinic were instrumental in developing novel ...

4. Induction Therapy With RO7790121 in Patients With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

   ... ulcerative colitis (UC). RO7790121 is a fully human immunoglobulin G1 monoclonal antibody (mAb) against tumor necrosis factor-like ligand 1A (TL1A). TL1A ...

5. Digestive Diseases News - Medical Professionals - Mayo Clinic

   New medications have improved pediatric IBD care, but surgery is still an important option to cure ulcerative colitis and reduce Crohn's disease symptoms.

6. Crohn's disease - Doctors and departments - Mayo Clinic

   Mayo Clinic researchers are working to improve diagnosis and treatment of Crohn's disease. Radiologists at Mayo Clinic were instrumental in developing novel ...

7. Crohn's disease - Doctors and departments - Mayo Clinic

   Mayo Clinic researchers are working to improve diagnosis and treatment of Crohn's disease. Radiologists at Mayo Clinic were instrumental in developing novel ...

8. Crohn's disease - Doctors and departments - Mayo Clinic

   Mayo Clinic researchers are working to improve diagnosis and treatment of Crohn's disease. Radiologists at Mayo Clinic were instrumental in developing novel ...

9. Crohn's disease - Doctors and departments - Mayo Clinic

   Mayo Clinic researchers are working to improve diagnosis and treatment of Crohn's disease. Radiologists at Mayo Clinic were instrumental in developing novel ...

10. Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD) - Mayo Clinic

    Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult ...